The stock may react negatively to flat 2026 revenue guidance despite improved margins and cost control, suggesting near-term growth headwinds persist. Watch for signs of U.S. commercial recovery and international sustainability. Debt refinancing improves liquidity, but profitability remains distant.
Price Chart
Executive Summary
Pulmonx reported mixed financial results for 2025, with full-year revenue up 8% to $90.5 million but Q4 revenue down 5% to $22.6 million. The company improved gross margins and reduced operating expenses, narrowing losses, but issued conservative 2026 guidance with revenue expected flat at $90M–$92M, signaling ongoing challenges in reaccelerating growth despite cost discipline and balance sheet strengthening.
Key Financial Metrics
Key Facts
- Full-year 2025 revenue: $90.5M (+8% YoY), driven by 23% growth in international markets
- Q4 2025 revenue: $22.6M (-5% YoY), with U.S. revenue down 11%
- Gross margin improved to 78% in Q4 (from 74% YoY) and 74% for full year
- Net loss narrowed to $54.0M in 2025 vs. $56.4M in 2024; Q4 loss improved to $10.4M from $13.2M
- Refinanced debt with $60M credit facility extending maturity to 2031
- 2026 revenue guidance: $90M–$92M (flat YoY), operating expenses expected to decrease to $113M–$115M
Financial Impact
Flat revenue guidance despite cost-cutting; cash burn expected to decrease from $32M in 2025 to $23M in 2026
Risk Factors
- U.S. revenue decline (-11% YoY in Q4) shows persistent commercial weakness
- Flat 2026 revenue guidance indicates limited near-term growth visibility
- Cash balance declined to $69.8M in 2025 and expected to fall further by ~$23M in 2026
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3249737 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | Press Release | $1.78 | awaiting T+60 | — | $1.95 (+9.55%) |
Jun 3, 2026 20w ago | Insider Cluster | $1.62 $2.38 | ▲ +46.91% | ▲ +45.29% | $1.95 (+20.37%) |
Jun 3, 2026 20w ago | Insider Cluster | $1.62 $2.38 | ▲ +46.91% | ▲ +45.29% | $1.95 (+20.37%) |
Apr 22, 2026 26w ago | DEFA14A | $1.28 $1.36 | ▲ +5.86% | ▲ +0.84% | $1.95 (+52.34%) |
Apr 15, 2026 27w ago | Press Release | $1.46 $1.46 | · 0.00% | ▼ −7.05% | $1.95 (+33.56%) |
Mar 5, 2026 33w ago | 8-K | $1.61 $1.59 | ▲ +1.24% | ▲ +12.54% | $1.95 (−21.12%) |
Mar 4, 2026 33w ago | 8-K | $1.61 $1.59 | ▼ −1.24% | ▼ −12.54% | $1.95 (+21.12%) |
Mar 4, 2026 33w ago | Press Release | $1.61 $1.59 | ▼ −1.24% | ▼ −12.54% | $1.95 (+21.12%) |
Mar 2, 2026 34w ago | Insider Cluster | $1.53 $1.57 | ▲ +2.95% | ▼ −6.38% | $1.95 (+27.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers